- •Both influenza myocarditis and COVID-19 mRNA vaccine–induced myocarditis are rare, but they might occur consecutively.
- •Careful attention is warranted after COVID-19 vaccination for patients with a history of myocarditis.
- Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine.N Engl J Med. 2020; 383: 2603-2615
- Myocarditis and pericarditis following COVID-19 mRNA vaccination: practical considerations for care providers.Can J Cardiol. 2021; 37: 1629-1634
- Myopericarditis after vaccination, vaccine adverse event reporting system (VAERS), 1990-2018.Vaccine. 2021; 39: 839-845
- Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases.Clin Immunol. 2020; 217 (108480)
- Recurrence of pericarditis after influenza vaccination: a case report and review of the literature.BMC Pharmacol Toxicol. 2018; 19: 20
- Potential cross-reactive immunity to SARS-CoV-2 from common human pathogens and vaccines.Front Immunol. 2020; 11 (586984)
- Myocarditis and inflammatory cardiomyopathy: current evidence and future directions.Nat Rev Cardiol. 2021; 18: 169-193
Ethics Statement: The research reported has adhered to the relevant ethical guidelines.
See page 352 for disclosure information.
User LicenseCreative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0) |
For non-commercial purposes:
- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article (private use only, not for distribution)
- Reuse portions or extracts from the article in other works
- Sell or re-use for commercial purposes
- Distribute translations or adaptations of the article
Elsevier's open access license policy